Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

ImmuPharma offers update on Lupuzor program

Sep. 26, 2017

NIH grant to support development of Cel-Sci's rheumatoid arthritis vaccine

Sep. 20, 2017

Boehringer Ingelheim receives positive opinion for adalimumab biosimilar Cyltezo

Sep. 18, 2017

Phase III trial of upadacitinib in rheumatoid arthritis meets all endpoints

Sep. 12, 2017

Daiichi Sankyo and Sanford Burnham Prebys begin clinical trial of DS-1211

Sep. 7, 2017

Promising RORgammaT inhibitors discovered at Merck & Co.

Sep. 5, 2017

EMD Serono details discovery of BTK inhibitor now in clinical development

Sep. 4, 2017

Phase II trial explores use of MBS-2320 in active rheumatoid arthritis

Aug. 31, 2017

European Commission approves adalimumab biosimilar Imraldi

Aug. 25, 2017

Symic Bio initiates phase II MODIFY2 study of SB-061 for osteoarthritis

Aug. 24, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...